128 related articles for article (PubMed ID: 4605362)
1. The validity of "identical matching placebos".
Blumenthal DS; Burke R; Shapiro AK
Arch Gen Psychiatry; 1974 Aug; 31(2):214-5. PubMed ID: 4605362
[No Abstract] [Full Text] [Related]
2. What conditions are necessary to assess antidepressant efficacy?
Quitkin FM; Klein DF
Arch Gen Psychiatry; 2000 Apr; 57(4):323-4. PubMed ID: 10768690
[No Abstract] [Full Text] [Related]
3. Proceedings of the National Conference on Clinical Trials Methodology.
Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):629-766. PubMed ID: 35299
[No Abstract] [Full Text] [Related]
4. The placebo problem remains.
Michels KB
Arch Gen Psychiatry; 2000 Apr; 57(4):321-2. PubMed ID: 10768689
[No Abstract] [Full Text] [Related]
5. Placebo protects subjects from nonresponse: a paradox of power.
Leon AC
Arch Gen Psychiatry; 2000 Apr; 57(4):329-30. PubMed ID: 10768693
[No Abstract] [Full Text] [Related]
6. Placebo controls: no news is good news.
Leber P
Arch Gen Psychiatry; 2000 Apr; 57(4):319-20. PubMed ID: 10768688
[No Abstract] [Full Text] [Related]
7. Clinical trials in anaesthesia.
Dundee JW
Proc R Soc Med; 1974 Jun; 67(7):586-8. PubMed ID: 4604235
[No Abstract] [Full Text] [Related]
8. Biological sex analysis in clinical research.
Woosley RL; Anthony M; Peck CC
J Womens Health Gend Based Med; 2000 Nov; 9(9):933-4. PubMed ID: 11103088
[No Abstract] [Full Text] [Related]
9. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.
Khan A; Warner HA; Brown WA
Arch Gen Psychiatry; 2000 Apr; 57(4):311-7. PubMed ID: 10768687
[TBL] [Abstract][Full Text] [Related]
10. Cancer institute's drug program reproved.
Sun M
Science; 1981 Nov; 214(4523):887-9. PubMed ID: 7302567
[No Abstract] [Full Text] [Related]
11. Scientific misconduct in investigational drug trials.
Shapiro MF; Charrow RP
N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
[No Abstract] [Full Text] [Related]
12. Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).
Cohn JB; Gottschalk LA
Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):313-5. PubMed ID: 45206
[No Abstract] [Full Text] [Related]
13. Thrombolysis for stroke.
Brott T
Arch Neurol; 1996 Dec; 53(12):1305-6. PubMed ID: 8970461
[No Abstract] [Full Text] [Related]
14. Single blind placebo in drug research.
Beck P
J Med Ethics; 2000 Dec; 26(6):477. PubMed ID: 11129852
[No Abstract] [Full Text] [Related]
15. Early evaluation of psychotropic drugs in man. A trial that failed.
Blackwell B; Shepherd M
Lancet; 1967 Oct; 2(7520):819-22. PubMed ID: 4167286
[No Abstract] [Full Text] [Related]
16. The use of doxepin in the treatment of symptoms of anxiety neurosis and accompanying depression: a collaborative controlled study.
Goldberg HL; Finnery RJ
Am J Psychiatry; 1972 Jul; 129(1):74-7. PubMed ID: 4556088
[No Abstract] [Full Text] [Related]
17. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida.
Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456
[No Abstract] [Full Text] [Related]
18. Statistical analysis to settle ethical issues?
Kraemer HC
Arch Gen Psychiatry; 2000 Apr; 57(4):327-8. PubMed ID: 10768692
[No Abstract] [Full Text] [Related]
19. Great expectations: is the U.S. doing its best to beat AIDS?. Interview by Don McLearn.
Parkman PD
FDA Consum; 1989 Feb; 23(1):36-8. PubMed ID: 10312853
[No Abstract] [Full Text] [Related]
20. FDA guidelines forthe clinical evaluation of psychotropic drugs--antidepressant and antianxiety drugs.
Psychopharmacol Bull; 1978 Apr; 14(2):45-63. PubMed ID: 26103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
